Abstract:Introduction: Excessive oxidant stress has been shown to damage cardiac tissue and result in impaired cardiac function. Animals with chronic heart failure (CHF) exhibit lower levels of antioxidant enzymes in many tissues including the heart, brain, and skeletal muscle (SkM). Nrf2 is a ubiquitous master transcription factor that regulates antioxidant proteins during enhanced oxidative stress. Earlier studies from this laboratory showed that exercise training was cardioprotective following ischemia reperfusion injury in mice. This protective effect was abrogated in mice in which the Nrf2 gene was deleted selectively in skeletal muscle. Given that skeletal muscle is approximately 40% of body weight and in light of recent findings on skeletal muscle derived extracellular vesicles, we sought to determine if up and downregulation of Nrf2 in skeletal muscle altered cardiac function. We hypothesized that skeletal muscle knockout of Nrf2 would impair cardiac function and the response to the beta 1 agonist dobutamine. Materials and Methods: Experiments were carried out in 37 males iMS-Keap1flox/flox and iMS-Nrf-2flox/flox (i.e. SkM specific) mice. Gene deletion was conditional upon the administration of the estrogen receptor agonist tamoxifen at 3 months of age; floxed mice given vehicle instead of tamoxifen were considered WT. The mice were assigned to 4 groups: Keap1 knockout (KO) (10), Keap1 WT (8), Nrf-2 KO (11), and Nrf-2 WT (8). Results: Keap1 deletion resulted in an increase in skeletal muscle hemoxygenase 1 (HO1) (p = 0.0286) while Nrf2 deletion resulted in a reduction in HO1 (p = 0.0286). However, there were no changes in the level of HO1 or other antioxidant proteins in the heart. Cardiac function was assessed with high frequency echocardiography (Vevo 3100). Systolic and diastolic function were analyzed. Up and downregulation of skeletal muscle Nrf2 did not evoke any change in either systolic or diastolic function. Conclusions: Previous studies have shown that Nrf2 upregulation salvaged cardiac function in mice subjected to either myocardial infarction or thoracic aortic constriction. Therefore, it may be that our lack of an effect of SkM specific Nrf2 manipulation is due to this study being carried out in normal animals and not in a disease setting such as CHF. In future work, this effect will be examined in mice with cardiac dysfunction. Supported by P0162222 and SURF from the APS This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Effects of acute ischemia and hypoxia in young and adult calsequestrin (CSQ2) knock-out and wild-type mice

Age-related Increase of Early Afterdepolarization in Calsequestrin-2 Knock-in Mouse Cardiomycyte

Human SERCA2a Levels Correlate Inversely with Age in Senescent Human Myocardium

Age-Dependent Electrical Remodelling In R33q Catecholaminergic Ventricular Tachycardia Knock-In Mouse Model

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart

The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.

Frequency distribution analysis of activation times and regional fibrosis in murine Scn5a+/- hearts: the effects of ageing and sex.

Alterations of L-Type Calcium Current and Cardiac Function in Camkii Delta Knockout Mice

Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia

Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice

Atrial Arrhythmogenicity in Aged Scn5a+/∆KPQ Mice Modeling Long QT Type 3 Syndrome and Its Relationship to Na+ Channel Expression and Cardiac Conduction

Age-related structural and functional changes of the intracardiac nervous system

AQP4 Knockout Mice Manifest Abnormal Expressions of Calcium Handling Proteins Possibly Due to Exacerbating Pro-Inflammatory Factors in the Heart

Abstract 11344: Impaired SIRT1 Nucleocytoplasmic Shuttling in the Senescent Heart During Ischemic Stress

Age- and Sex-Dependent Caveolar Gene Expression in Normoxic and Post-Ischemic Mouse Hearts

The Role of Skeletal Muscle Nrf2 on Cardiac Function in Mice

Preserved cardiac performance and adrenergic response in a rabbit model with decreased ryanodine receptor 2 expression

Enhanced gene expression of Na<sup>+</sup>/Ca<sup>2+</sup>exchanger attenuates ischemic and hypoxic contractile dysfunction

LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice

Phylogenetic and biochemical analysis of calsequestrin structure and association of its variants with cardiac disorders

Mutation of the SERCA-Reactive Cysteine-674 to Serine Attenuates Myocyte Apoptosis and Heart Failure in Mice With Chronic Pressure Overload